Hormone replacement therapy: to use or not to use?

被引：11
|
作者：
Baber, RJ [1 ]
O'Hara, JL
Boyle, FM
机构：
[1] Univ Sydney, Dept Obstet & Gynaecol, Fac Med, Sydney, NSW 2006, Australia
[2] Univ Sydney, No Clin Sch, Sydney, NSW 2006, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2003年 / 178卷 / 12期
关键词：
D O I：
10.5694/j.1326-5377.2003.tb05389.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The main indication for hormone replacement therapy (HRT) is to control menopausal symptoms and improve quality of life. Ideally, withdrawal of HRT should be attempted after 4-5 years of therapy. HRT reduces fracture risk and remains appropriate therapy for osteoporosis, particularly in women with symptoms. HRT is not appropriate for primary or secondary cardioprotection. HRT leads to a small increase in breast cancer incidence, which increases with duration of therapy and age. HRT increases the risk of thromboembolism. Patient management and therapy should be reviewed annually with risk-benefit counselling.
引用
收藏
页码：630 / 633
页数：4
相关论文
共 50 条
  • [21] Use of hormone replacement therapy - Hormone replacement therapy may not always be right choice to prevent cardiovascular disease
    Panico, S
    Galasso, R
    Celentano, E
    Frova, L
    Capocaccia, R
    Berrino, F
    [J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7058): : 687 - 687
  • [22] Women doctors' use of hormone replacement therapy - High prevalence of use is not confined to doctors
    Banks, E
    Crossley, B
    English, R
    Richardson, A
    [J]. BRITISH MEDICAL JOURNAL, 1996, 312 (7031): : 638 - 638
  • [23] CHANGES IN THE USE OF HORMONE REPLACEMENT THERAPY IN SOUTH-AUSTRALIA
    MACLENNAN, AH
    TAYLOR, AW
    WILSON, DH
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1995, 162 (08) : 420 - 422
  • [24] Use of hormone replacement therapy among Danish nurses in 1993
    Hundrup, YA
    Obel, EB
    Rasmussen, NK
    Philip, J
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (03) : 194 - 201
  • [25] Impact of hormone replacement therapy use on mammographic screening outcomes
    Beckmann, Kerri R.
    Farshid, Gelareh
    Roder, David M.
    Hiller, Janet E.
    Lynch, John W.
    [J]. CANCER CAUSES & CONTROL, 2013, 24 (07) : 1417 - 1426
  • [26] Change in the use of hormone replacement therapy and the incidence of fracture in Oslo
    H. E. Meyer
    C. M. Lofthus
    A. J. Søgaard
    J. A. Falch
    [J]. Osteoporosis International, 2009, 20 : 827 - 830
  • [27] The use and discontinuation of hormone replacement therapy in women in South China
    Chu, K.
    Song, Y.
    Chatooah, N. D.
    Weng, Q.
    Ying, Q.
    Ma, L.
    Qu, F.
    Zhou, J.
    [J]. CLIMACTERIC, 2018, 21 (01) : 47 - 52
  • [28] Physician specialty is significantly associated with hormone replacement therapy use
    Levy, BT
    Ritchie, JM
    Smith, E
    Gray, T
    Zhang, W
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 101 (01): : 114 - 122
  • [29] Hormone replacement therapy in children: The use of growth hormone and IGF-I
    Pfaeffle, Roland
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 29 (03) : 339 - 352
  • [30] Change in the use of hormone replacement therapy and the incidence of fracture in Oslo
    Meyer, H. E.
    Lofthus, C. M.
    Sogaard, A. J.
    Falch, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 (05) : 827 - 830
12345